Tadalafil and Premature Ejaculation: What the Research Actually Says

Last reviewed July 9, 2026 by Dr. Michael Rio, PharmD, a licensed pharmacist.

Tadalafil is not FDA-approved for premature ejaculation, and it's worth saying that plainly up front, since the two conditions get discussed together often enough that the distinction can get lost. This page summarizes what has actually been studied and why any use for this purpose would be considered off-label — something a prescriber may or may not consider appropriate on a case-by-case basis, not something this site can recommend.

What's Been Studied

Premature ejaculation and erectile dysfunction sometimes occur together, and some research has looked at whether PDE5 inhibitors, including tadalafil, provide any secondary benefit for ejaculatory control — particularly in men who have both conditions at once. Results across these studies have been mixed and are generally considered less robust than the evidence supporting tadalafil's approved uses. Medicines with dedicated approval for premature ejaculation work through a different mechanism entirely (typically affecting serotonin pathways) and are a separate category from PDE5 inhibitors.

Why This Matters for a Prescriber Conversation

If premature ejaculation is the primary concern rather than erectile function, a prescriber is likely to discuss options actually studied and approved for that specific concern, rather than starting with a medicine approved for something else. If both concerns are present together, that combination is exactly the kind of nuanced case where a full evaluation — not a self-directed choice based on a search result — makes the most sense.

Where to Go From Here

If erectile function is part of what's being evaluated, our tadalafil overview and dosage guide are a reasonable starting point for background before a prescriber conversation. If premature ejaculation is the main or only concern, that's worth raising as its own topic rather than assuming the same medicine applies to both.

Sources and Further Reading

MR

Medically reviewed by Dr. Michael Rio, PharmD, a licensed pharmacist. Reviewed July 9, 2026. See our editorial policy for how content on this site is researched and kept current.